Abstract
Pinacidil is a new and potent vasodilator, which has recently been used in the treatment of various forms of hypertension. In this study pharmacokinetic parameters were determined following administration of intravenous (0·2 mg/kg) and capsule (12·5 mg) formulations of pinacidil to twelve healthy volunteers.
The serum half life (t½ and volume of distribution (Vd) of pinacidil were 204 ± 0·40 h and 1·4 ± 0·4 l/kg respectively, while the elimination rate constant (k el) was 0·34 ± 0·07 h1
The mean bioavailability of pinacidil (capsule formulation) was 57% ± 16 S.D.
Mild side-effects such as dizziness, headache and fatigue were noted in two volunteers following intravenous administration of pinacidil, while no side effects were reported with the oral formulation.
Get full access to this article
View all access options for this article.